The Central Drugs Standard Control Organization (CDSCO), drug regulator for India's Health Ministry, approved two more Covid vaccines, Corbevax and Covovax, as also the anti-viral drug Molnupiravir to treat adult patients with COVID-19 as also those who have a high risk of progression of the disease. Corbevax: This vaccine is...
Merck Licenses New Covid Treatment to 5 Indian Companies
Merck has inked pacts with multiple Indian companies: Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals to license and produce a forthcoming treatment for Covid-19. The company, formally known as MSD, is in the process of developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The investigational oral antiviral...